#LCSM Transcript
Healthcare social media transcript of the #LCSM hashtag.
– ().
See #LCSM Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | The ROS1ders, Inc. @ros1cancer Our work has doubled the number of available ROS1+ cell lines available for research. Learn more about the ROS1 Cancer Model Project, what it has accomplished thus far, and how you as a #ROS1 patient (or their physician) can help: https://t.co/LdD1uxqJw5 #LCSM #cancerSM |
 | Cancer Research Institute @CancerResearch "The preliminary data with neoadjuvant immunotherapy or neoadjuvant chemotherapy plus immunotherapy shows much higher complete responses and pathologic response rates than with chemotherapy alone," says Dr. Paul A. Bunn of @UofDenver. #lcsm https://t.co/d7HP7vL2FA |
| The ROS1ders, Inc. @ros1cancer The ROS1 Cancer Model Project has doubled the number of #ROS1 cell lines available for research. Learn more about the project, what it has accomplished thus far, and how you as a #ROS1 patient (or their physician) can help: https://t.co/LdD1uxqJw5) #LCSM #cancerSM https://t.co/RHFb51AsyH |
 | CHEST @accpchest Meeting unmet needs in #SCLC: https://t.co/cIppidNlcR #lungcancer #lcsm @sloan_kettering @ginacolumbusonc @OncLive https://t.co/QlBk364oPR |
 | Linda L Wortman @LindaLWortman GO2 I’m shouting out THANK YOU |
 | Shankar Siva @_ShankarSiva 52 🇯🇵patients w #lungcancer who underwent both surgery and SABR responded to survey on preference https://t.co/FeYnmm7IOR - If asked to pick again 38/52 would pick SABR. In hypothetical of surgery having >20% OS benefit over SABR, only 12/52 would pick surgery over SABR. #lcsm https://t.co/MDOUgMeqSn |
 | OurWarOnCancer @OurWarOnCancer RT @jillfeldman4: Why does lung cancer research matter? I was 13 when my dad died of lc at 41 (3 mth @ dx), I was 28 when my mom died of lc at 54 (6 mth @ dx). Thanks to research, yesterday I TURNED 50-10 1/2 yrs @ I was dx w/lc! Fun day @Cubs w/hubby & kids (despite a loss) #LCSM #ResearchMatters https://t.co/2UbF99ymKg |
 | Kim Moran-MacIntosh 🇨🇦 🍀 @Kamacintosh RT @ros1cancer: The ROS1 Cancer Model Project has doubled the number of #ROS1 cell lines available for research. Learn more about the project, what it has accomplished thus far, and how you as a #ROS1 patient (or their physician) can help: https://t.co/LdD1uxqJw5) #LCSM #cancerSM https://t.co/RHFb51AsyH |
 | Conservatives4PublicOption @PubOptConserv RT @OurWarOnCancer: https://t.co/YmYQGh4KQy via @fredhutch #LCSM |
| Shankar Siva @_ShankarSiva 52 🇯🇵patients w #lungcancer who underwent both surgery and SABR responded to survey on preference https://t.co/FeYnmm7IOR - If asked to pick again 38/52 would pick SABR. In hypothetical of surgery having >20% OS benefit over SABR, only 12/52 would decisively favor surgery. #lcsm https://t.co/4HSM9ybuhI |
 | Dr. Jan Marie Eberth @jmeberth RT @DrewMoghanaki: Great to see @AmerMedicalAssn's support to help us all reduce lung cancer mortality! #lcsm https://t.co/Sx9sQS14FQ |
 | CancerGeek @CancerGeek RT @findlungcancer: Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening #lcsm @DrewMoghanaki @BrendonStilesMD @CrisAlvaradoMD @lung_ca_screen @ellakaz https://t.co/zcOoZE2Mph |
 | OncLive.com @OncLive @teekayowo, MD, PhD, MSCR, of @WinshipAtEmory discusses the results of the NLST and NELSON trials and the next steps that need to be addressed with lung cancer screening #lcam #lcsm https://t.co/dSZ8rQSyNQ |
 | Denny Keller @hrblock_21 RT @boehringerus: Updated #RWE published today in @fsgfon demonstrate impact of sequential therapy for EGFR M+ #NSCLC patients. Read more: https://t.co/QAPzzbgQRS #LCSM https://t.co/6tlmQmSG64 |
#LCSM content from Twitter.